Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-Center, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia Following Augmentation of Dialysate Potassium

NCT05535920 is registered in ClinicalTrials.gov with NephroNet, Inc. as lead sponsor.

NCT NCT05535920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05535920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-Center, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia Following Augmentation of Dialysate Potassium
Lead sponsor
NephroNet, Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 14, 2022
Completion date
April 1, 2024
Enrollment
88 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia